Serologic markers for Chlamydia pneumoniae in asthma.

Area of Science:

• Infectious Diseases
• Respiratory Medicine
• Immunology

Background:

• Chlamydia pneumoniae infection is a suspected trigger for asthma development, particularly when asthma onset follows acute respiratory infections.
• Asthma management in primary care often addresses acute respiratory illness as an initiating factor.

Purpose of the Study:

• To investigate the association between serologic markers of Chlamydia pneumoniae and adult-onset asthma following respiratory illness (asthma associated with infection - AAWI).
• To differentiate AAWI from other asthma types and non-asthmatic respiratory conditions using serologic evidence of C. pneumoniae.

Main Methods:

• Serum samples from 164 outpatients were analyzed for C. pneumoniae-specific IgG and IgA antibodies.
• Chlamydial heat shock protein 60 (CHSP60) antibody levels were measured, with positive cases further tested for C. pneumoniae-specific IgE antibodies.
• Participants included patients with AAWI, non-AAWI, acute bronchitis, and asymptomatic controls.

Main Results:

• Elevated IgG and IgA seroreactivity to C. pneumoniae was significantly higher in patients with acute bronchitis and AAWI compared to non-AAWI and controls (P < .02).
• CHSP60 antibodies were more prevalent in AAWI patients (19%) than in non-AAWI patients (3%) (P = .02).
• Persistent seroreactivity was observed in seropositive asthma patients with available serial samples.

Conclusions:

• Serologic evidence of Chlamydia pneumoniae infection is associated with acute bronchitis and asthma that emerges after respiratory illness.
• Measuring serologic responses to C. pneumoniae may offer a valuable tool for classifying and diagnosing asthma, particularly infection-associated types.